Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Allogene Therapeutics, Inc. (ALLO)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18
   10-K10-K10-K10-K10-K8-K
Net income  -332.6-257.0-250.2-184.6-211.5-211.5
Depreciation and amortization   [+]14.310.57.65.01.5 
Stock-based compensation  83.680.865.346.118.6 
Change in working capital   [+]106.459.487.447.554.3 
Other operating activities  -92.2-78.5-25.2-51.392.5 
Cash from operations  -220.5-184.8-115.1-137.4-44.7 
   
Capital expenditures  -5.2-21.4-66.0-50.8-3.2 
Other cash from investing  111.4185.1-439.2214.9-629.6 
Cash from investing  106.2163.7-505.1164.1-632.8 
   
Issuance of common stock, net    595.7 343.7 
Option exercises  3.08.38.83.0  
Other cash from financing  5.920.346.761.9427.5 
Cash from financing  3.012.0633.659.0771.2 
   
Free cash flow  -225.7-206.3-181.1-188.1-47.9 
        Per share (diluted)  ($1.58)($1.52)($1.50)($1.86)($1.65) 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy